Accelerate Therapeutics to Market. Expedite R&D. Improve CMC Efficiency.
Join the leading conference in Europe to access new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies - from discovery to market.
TIDES Europe by the Numbers
+
Attendees
+
Speakers
+
Exhibitors
3
Immersive Workshops
3
Content-Driven Tracks
Meet the 2026 TIDES Europe's Expert Speakers: Leaders in Oligonucleotide & Peptide Therapeutics
Cross-Pollinate Expertise Across Oligonucleotides, Peptides, mRNA, Genome Editing and Drug Delivery
Cross-Fertilize Ideas and Best Practices with Industry Experts Across Multiple Discipline Areas:
The TIDES Europe conference agenda features scientific tracks covering in-depth discovery, development and manufacturing strategies, trends and technologies across the entire oligonucleotide and peptide spectrum and areas of focus below.
Oligonucleotide Chemistry, Manufacturing & Controls
Comprehensive CMC, analytical, manufacturing and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development.
Oligonucleotide Discovery, Preclinical and Clinical
Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.
Peptide Chemistry, Manufacturing & Controls
Improve process efficiencies and overcome challenges in process development, CMC and manufacturing. Understand regulatory expectations, new technologies and alternative approaches for emerging complex molecules.
Peptide Discovery, Preclinical and Clinical
Explore new frontiers in peptide synthesis, discovery, design and engineering to improve targeting, delivery and drug-like properties. Case studies on the latest preclinical and clinical successes of peptides and peptide-like scaffolds and structures.
mRNA Therapeutics and Genome Editing
Hear updates on discovery strategies, clinical progress and CMC approaches for mRNA therapeutics and vaccines from industry-leading companies
Macromolecular Drug Delivery
Learn about the latest technologies and approaches to overcome the delivery challenges of oligonucleotides, peptides, mRNA and other macromolecules and discover new delivery strategies for genome editing

What's TIDES Europe Like?
Engage Quality Decision-Makers at TIDES Europe!
Whether you're looking to generate quality leads, showcase thought leaders, or reinforce your brand, collaborate with us to identify custom sponsorship opportunities to help you reach your business objectives.
Contact us to begin customizing your event presence today:
Companies #, A-F: Jennifer Wickett, JWickett@informaconnectls.com
Companies G-Z: Michael Moriarty, MMoriarty@informaconnectls.com
BioXconomy
BioXconomy, owned by Informa, engages the industry, builds community, and connects life sciences professionals to current, credible information, products and services relevant to their business. As the official media partner for Informa Life Sciences flagship events including: TIDES Europe, TIDES USA, BIO-Europe and LSX World Congress - BioXconomy offers our audiences exclusive event-based insights, updated news and features, and interactive media. Find out the latest developments in Modalities here.
Get the Latest Event Updates
FAQs
What is TIDES Europe?
TIDES Europe 2026 is Europe's premier event for oligonucleotide and peptide therapeutics, bringing together over 900 attendees from across the pharmaceutical and biotech industries. The conference focuses on the latest advances in discovery, development, and manufacturing of oligonucleotide and peptide therapeutics.
When and where is TIDES Europe 2026?
TIDES Europe will be held on 3-5 November 2026 at the RAI Amsterdam Convention Centre, in Amsterdam, Netherlands. We look forward to seeing you there!
Who usually attends TIDES Europe?
Our event is designed for professionals working in oligonucleotide and peptide therapeutics, including R&D scientists, CMC specialists, regulatory affairs professionals, business development executives, and academic researchers. Anyone involved in the development, manufacturing, or commercialization of nucleic acid therapeutics will benefit from attending.
What networking opportunities are available at TIDES Europe?
TIDES Europe offers extensive networking opportunities including dedicated networking breaks, evening receptions, interactive panel discussions, and an exhibition hall featuring 60+ companies. We also provide one-to-one meeting scheduling capabilities through our conference platform, Connect Me.
How many attendees are expected?
TIDES Europe typically attracts over 900 attendees from across the pharmaceutical and biotech industries, including representatives from major pharmaceutical companies, emerging biotechs, academic institutions, and service providers.
Are group discounts available?
Yes, group discounts from 10% - 50% are available for organizations sending multiple attendees. Take a look at our Group Rates page or contact Tayla Thomas at Tayla.Thomas@informa.com for more information.
Can I attend virtually or only in-person?
Yes, we offer both in person attendance and a digital participation option for those unable to attend in person. Digital attendees can access session recordings, digital networking features, and virtual exhibition content through the online platform.







